| Literature DB >> 27581076 |
Pilar López-Nieva1,2, Manuel Malavé1,2, Laura González-Sánchez1,2,3, José Fernández-Piqueras4,5,6,7, Pablo Fernández-Navarro8,9, Javier Santos10,11,12,13.
Abstract
BACKGROUND: Radio-Adaptive Response (RAR) is a biological defense mechanism whereby exposure to low dose ionizing radiation (IR) mitigates the detrimental effects of high dose irradiation. RAR has been widely observed in vivo using as endpoint less induction of apoptosis. However, sex differences associated with RAR and variations between males and females on global gene expression influenced by RAR have not been still investigated. In addition, the response to radiation-induced apoptosis is associated with phosphorylation of TRP53 at both the serine 15 (ser-18 in the mouse) and serine 392 (ser-389 in mice) residues, but the role of these two phosphorylated forms in male and female RAR remains to be elucidated.Entities:
Keywords: Caspase-3; Dlc1; Fis1; Phosphorylation of TRP53 at serine 18 and serine 389; Radio-adaptive response; Sex differences; Thymocyte apoptosis; cDNA microarrays
Mesh:
Substances:
Year: 2016 PMID: 27581076 PMCID: PMC5007679 DOI: 10.1186/s12864-016-3036-0
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Fig. 1Signal cascade diagram showing working plan to test the proposed hypotheses
Fig. 2Dissimilar adaptive response of thymocyte apoptosis induced by priming low dose X-ray irradiation in C57BL/6 male and female mice. a Representative results of the Western blotting assay for the expression of caspase-3. HIGH indicates exposure to 1.75 Gy of γ-rays. RAR represents radio-adaptive response. LOW denotes exposure to 0.075 Gy of X-rays. b Quantitative analysis of caspase-3 protein levels. Amounts of caspase-3 were first normalized to β-actin, and then the ratio of each normalized value to its corresponding non-irradiated control value was calculated. Histograms represent the mean ± SD of normalized values obtained from three independent experiments. Open columns, non-irradiated thymocytes. Light gray columns, thymocytes exposed to 1.75 Gy of γ-rays. Dark gray columns, thymocytes treated with priming low dose X-irradiation (0.075 Gy) 6 h before a challenging high dose of γ-rays (1.75 Gy). Black columns, thymocytes exposed to 0.075 Gy of X-rays
Multivariate analysis of caspase 3 protein expression
| Gene | Variable | Value | Estimate | t value |
|
|
|---|---|---|---|---|---|---|
| Caspase 3 | Sex | Female | ref | 1.010E-09 | ||
| Male | −6.559E-03 | −0.043 | 0.966 | |||
| Treatment | Control | ref | <2.2E-16 | |||
| High | 5.502 | 36.221 | <2E-16 | |||
| RAR | 2.592 | 17.062 | 1.090E-11 | |||
| Low | 3.651 | 24.040 | 5.520E-14 | |||
| Sex*Treatment | Male(Control)*Female(Control) | ref | 9.483E-08 | |||
| Male(High)*Female(High) | −1.752 | −8.156 | 4.310E-07 | |||
| Male(RAR)*Female(RAR) | −1.829 | −8.513 | 2.450E-07 | |||
| Male(Low)*Female(Low) | −0.221 | −1.029 | 0.319 |
Sex*Treatment interaction term between sex and radiation treatment, ref reference value, Estimat e regression coefficient, t value t test values; p value* p value from F test in ANOVA analysis, High exposure to 1.75 Gy of g-rays, RAR radio-adaptive response, Low exposure to 0.075 Gy of X-rays
Genes involved in apoptosis signaling that show differential transcriptional expression between male and female radioadaptive thymocytes
| Probe Name | Gene Symbol | Gene description | log2FC | FDRa | FDRb | GO.Ontology |
|---|---|---|---|---|---|---|
| A_51_P449995 |
| Complement component 6 | −1.64 | 9.89E-03 | 2.75E-02 | GO:0006919 |
| A_51_P458451 |
| Adiponectin | 2.36 | 2.51E-03 | 3.76E-03 | GO:0033034 |
| A_51_P473170 |
| Tumor necrosis factor superfamily member 4 | 2.06 | 1.67E-04 | 2.61E-03 | GO:0043066 |
| A_52_P304720 |
| Cytokine receptor-like factor 1 | −1.97 | 1.54E-03 | 4.64E-03 | GO:0043524 |
| A_52_P442710 |
| Neuro-derived neurotrophic factor | 2.18 | 2.20E-04 | 2.06E-03 | GO:0043524 |
| A_52_P464831 |
| Distal-less homeobox 1 | −2.45 | 1.50E-04 | 4.61E-03 | GO:0043524 |
| A_55_P1952533 |
| Fission 1 (Mitochondrial Outer Membrane) Homolog ( | −2.94 | 1.06E-04 | 9.86E-04 | GO:0001836 |
| A_55_P1974019 |
| Death associated protein kinase 1 | 2.18 | 9.38E-04 | 7.94E-03 | GO:0008624 |
| A_55_P1974845 |
| Phosphodiesterase 1A, Calmodulin-Dependent | −2.24 | 2.46E-04 | 3.24E-03 | GO:0034391 |
| A_55_P1977431 |
| Cholecystokinin | 1.79 | 2.67E-04 | 2.45E-03 | GO:0005044 |
| A_55_P1982400 |
| Scavenger Receptor Class A, Member 5 | −2.91 | 1.72E-04 | 3.91E-03 | GO:0005044 |
| A_55_P2042101 |
| Prune Homolog 2 ( | −2.17 | 2.67E-04 | 6.68E-03 | GO:0006917 |
| A_55_P2044143 |
| Lysyl Oxidase-Like 4 | −2.29 | 4.37E-05 | 3.99E-04 | GO:0005044 |
| A_55_P2089710 |
| Endothelin Receptor Type B | 2.57 | 4.02E-04 | 1.69E-02 | GO:0043066 |
| A_55_P2144686 |
| Deleted In Malignant Brain Tumors 1 | 2.78 | 2.61E-05 | 2.46E-03 | GO:0005044 |
| A_55_P2268221 |
| Rho GTPase Activating Protein 10 | −2.49 | 2.54E-04 | 3.04E-03 | GO:0043066 |
| A_55_P2280821 |
| Deleted in liver cancer 1 | −2.53 | 2.02E-05 | 4.49E-04 | GO:0006919 |
log FC log2 Fold Change in gene expression between male and female under RAR treatment; a minus sign denotes down-regulation in radioadapted thymocytes of males as compared with females; FDR FDR obtained from the moderated t-test for identifying differentially expressed genes between male and female RAR, FDR FDR obtained from two-way ANOVA for assessing gene expression differences between male and female regarless treatment
Fig. 3Different protein levels of phosphoserine-18-TRP53, phosphoserine-389-TRP53 and activated-p38MAPK after priming low dose X-ray irradiation in thymocytes of C57BL/6 male and female mice. Left panels, representative Western blots. HIGH indicates exposure to 1.75 Gy of γ-rays. RAR represents radio-adaptive response. LOW denotes exposure to 0.075 Gy of X-rays. Right panels, quantitative data showing normalized relative protein amounts. Each column represents mean of three independent experiments; bars, SD. Open histograms, non-treated thymocytes. Light gray histograms, thymocytes exposed to high dose (1.75 Gy) γ-irradiation. Dark gray histograms, thymocytes exposed to the adaptive regimen of radiation. Black histograms, thymocytes treated with low dose X-irradiation (0.075 Gy). a-b, TRP53. c-d Phosphorylated form of TRP53 at serine 18. e-f Phosphoserine-389-TRP53. g-h Phospho-(Thr180/Tyr182)-p38MAPK
Multivariate analysis of TRP53, phosphoserine-18-TRP53, phosphoserine-389-TRP53 and p38MAPK protein expression
| Gene | Variable | Value | Estimate | t value |
|
|
|---|---|---|---|---|---|---|
| TRP53 | Sex | Female | ref | 0.1805 | ||
| Male | −0.028 | −0.305 | 0.764249 | |||
| Treatment | Control | ref | 1.033E-10 | |||
| High | 1.02 | 11.110 | 6.23e-09 | |||
| RAR | 0.438 | 4.779 | 0.000205 | |||
| Low | 0.787 | 8.590 | 2.18e-07 | |||
| Sex*Treatment | Male(Control)*Female(Control) | ref | 0.2020 | |||
| Male(High)*Female(High) | 0.104 | 0.800 | 0.435191 | |||
| Male(RAR)*Female(RAR) | −0.183 | −1.417 | 0.175527 | |||
| Male(Low)*Female(Low) | −0.065 | −0.501 | 0.623391 | |||
| phosphoserine-18-TRP53 | Sex | Female | ref | 0.0004246 | ||
| Male | −0.126 | −0.979 | 0.3420 | |||
| Treatment | Control | ref | <2.2E-16 | |||
| High | 13.57 | 105.038 | <2E-16 | |||
| RAR | 9.49091 | 73.469 | <2E-16 | |||
| Low | 12.67 | 98.071 | <2E-16 | |||
| Sex*Treatment | Male(Control)*Female(Control) | ref | 7.153E-11 | |||
| Male(High)*Female(High) | 0.516 | 2.825 | 0.0122 | |||
| Male(RAR)*Female(RAR) | −2.101 | −11.498 | 3.81e-09 | |||
| Male(Low)*Female(Low) | 0.947 | 5.185 | 9.03E-05 | |||
| phosphoserine-389-TRP53 | Sex | Female | ref | 1.133E-05 | ||
| Male | 0.058 | 0.854 | 0.406 | |||
| Treatment | Control | ref | <2.2E-16 | |||
| High | 4.041 | 59.194 | <2E-16 | |||
| RAR | 7.419 | 108.665 | <2E-16 | |||
| Low | 7.739 | 113.354 | <2E-16 | |||
| Sex*Treatment | Male(Control)*Female(Control) | ref | <2.2E-16 | |||
| Male(High)*Female(High) | 1.748 | 18.102 | 4.43E-12 | |||
| Male(RAR)*Female(RAR) | 0.909 | 9.416 | 6.30E-08 | |||
| Male(Low)*Female(Low) | −2.035 | −21.076 | 4.26E-13 | |||
| phospho-Thr 180/Tyr 182-p38MAPK | Sex | Female | ref | 1.196E-05 | ||
| Male | 4.586E-16 | 0.000 | 1.0000 | |||
| Treatment | Control | ref | 1.368E-15 | |||
| High | −1.923e-01 | −1.918 | 0.0732 | |||
| RAR | 1.291 | 12.874 | 7.38E-10 | |||
| Low | −1.535e-01 | −1.531 | 0.1453 | |||
| Sex*Treatment | Male(Control)*Female(Control) | ref | 3.259E-08 | |||
| Male(High)*Female(High) | −1.257e-01 | −0.886 | 0.3886 | |||
| Male(RAR)*Female(RAR) | 1.348 | 9.507 | 5.53E-08 | |||
| Male(Low)*Female(Low) | 2.765E-02 | 0.195 | 0.8479 |
Sex*Treatment interaction term between sex and radiation treatment, ref reference value, Estimat e regression coefficient, t value t test values, p value* p value from F test in ANOVA analysis, High exposure to 1.75 Gy of g-rays, RAR radio-adaptive response, Low exposure to 0.075 Gy of X-rays